Current Edition


Halozyme, doubling down on a licensing strategy, buys a drug delivery biotech for nearly $1B

Dive Brief: Halozyme Therapeutics, a San Diego-based company whose business revolves around a type of drug delivery technology, announced Wednesday plans to expand its offerings …

Continue Reading →

Alnylam sues Pfizer, Moderna over technology used in COVID vaccines

Dive Brief: Alnylam is accusing Pfizer and Moderna of violating a patent it holds for technology that Alnylam claims the two companies use in their …

Continue Reading →

Intellia, expanding in gene editing, buys startup Rewrite for $45M

Dive Brief: Intellia Therapeutics, a leading developer of CRISPR-based medicines, on Thursday said it will buy privately held Rewrite Therapeutics for $45 million, as it …

Continue Reading →

Under pressure to share technology, Moderna to build vaccine factory in Africa

The announcement from Moderna comes amid criticism of the drugmaker, and other Western companies with authorized coronavirus vaccines, for not doing more to share their …

Continue Reading →

AstraZeneca strikes deal with university spinoff to turn RNA into drugs

The success of the mRNA vaccines developed by Moderna and BioNTech has drawn significant attention, and new funding, to the technology that allows drug developers …

Continue Reading →
Big Memory technology

Accelerating Single-Cell Genomic Sequencing with Big Memory

When fighting the global spread of a pandemic or working to fight cancer, faster time-to-discovery saves lives. For this critical bioscience work, scientists have employed …

Continue Reading →

Shuwen Debuts it’s CODAR-ARMS PCR Liquid Biopsy Technology at ASCO 2018

Shuwen Biotech, a leading provider of innovative diagnostic products and medical diagnostic services, announced that studies based on its proprietary high-sensitivity CODAR-ARMS PCR liquid biopsy …

Continue Reading →